10,527
Views
24
CrossRef citations to date
0
Altmetric
Editorial

Academia–pharma partnerships for novel drug discovery: essential or nice to have?

&
Pages 537-540 | Received 07 Feb 2017, Accepted 07 Apr 2017, Published online: 17 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Temmy Sunyoto. (2020) Partnerships for better neglected disease drug discovery and development: how have we fared?. Expert Opinion on Drug Discovery 15:5, pages 531-537.
Read now
Gervais Bérubé. (2019) How to utilize academic research efforts in cancer drug discovery. Expert Opinion on Drug Discovery 14:4, pages 331-334.
Read now
Anuradha Roy. (2019) Challenges with risk mitigation in academic drug discovery: finding the best solution. Expert Opinion on Drug Discovery 14:2, pages 95-100.
Read now
Ashok Vaidya, Anuradha Roy & Rathnam Chaguturu. (2018) How to rekindle drug discovery process through integrative therapeutic targeting?. Expert Opinion on Drug Discovery 13:10, pages 893-898.
Read now

Articles from other publishers (20)

Bastian Rake, Kaushik Sengupta, Lena Lewin, Anna Sandström & Maureen McKelvey. (2023) Doing science together: Gaining momentum from long-term explorative university–industry research programs. Drug Discovery Today 28:9, pages 103687.
Crossref
Shaofei Shen, Fangjuan Zhang, Yali Zhang, Yi Li, Yanbing Niu, Long Pang & Jinyi Wang. (2023) Construction of multiple concentration gradients for single-cell level drug screening. Microsystems & Nanoengineering 9:1.
Crossref
Susan Miller, Walter Moos, Barbara Munk, Stephen Munk, Charles Hart & David Spellmeyer. 2023. Managing the Drug Discovery Process. Managing the Drug Discovery Process 417 511 .
Sutti Sooampon, Pagaporn Pantuwadee Pisarnturakit & Sireerat Sooampon. (2021) Fostering healthcare innovation: a qualitative study of dental implant product development by Thai university researchers. International Journal of Health Governance 26:4, pages 408-417.
Crossref
João Lucas Hana Frade, Jorge Henrique Caldeira de Oliveira & Janaina de Moura Engracia Giraldi. (2021) Advertising in streaming video: An integrative literature review and research agenda. Telecommunications Policy 45:9, pages 102186.
Crossref
Israel S. Gloger, Rosana Felice & Kevin P. Madauss. (2021) Trust in Science: a novel research partnership model in Latin America. Nature Reviews Drug Discovery 20:8, pages 571-572.
Crossref
Donald J. AbrahamRoland E. Dolle, Laurel K. McGrane, James W. Janetka, Jared T. Hammill, Rodney Kiplin Guy, Anjan Debnath, Peter M. Cheuka, Claire Le Manach, Kelly Chibale, Ake Elhammer, Martin Handfield, Michael J. Dawson, Stefano Donadio, Jae H. Park & Alan Joslyn. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 95 .
Sophia Malandraki-Miller & Paul R. Riley. (2021) Use of artificial intelligence to enhance phenotypic drug discovery. Drug Discovery Today 26:4, pages 887-901.
Crossref
Yadollah Omidi & Hossein Omidian. (2021) Transformative dynamism in pharmaceutical and biomedical research: Complexity of integration of innovative R & D hubs. BioImpacts 11:3, pages 227-233.
Crossref
Stefanie Broes, Robbe Saesen, Denis Lacombe & Isabelle Huys. (2020) Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer. Clinical and Translational Science 14:1, pages 47-53.
Crossref
Geoffrey Kabue Kiriiri, Peter Mbugua Njogu & Alex Njoroge Mwangi. (2020) Exploring different approaches to improve the success of drug discovery and development projects: a review. Future Journal of Pharmaceutical Sciences 6:1.
Crossref
Vijay Mahant. (2020) Translational medicines “Ecosystem”. Journal of Translational Medicine 18:1.
Crossref
S. Sethu K. Reddy & Shing Chao. (2023) Academic Collaborations with Industry: Lessons for the Future. Journal of Investigative Medicine 68:8, pages 1305-1308.
Crossref
Astrid Stefanía Duarte Trujillo, Javier Alexander Jiménez Forero, Julio Amilcar Pineda Insuasti, Camila Alejandra González Trujillo & Magdiel García Juarez. (2020) Extracción de sustancias bioactivas de <i>Pleurotus ostreatus</i> (Pleurotaceae) por maceración dinámica. Acta Biológica Colombiana 25:1, pages 61-74.
Crossref
Farhad Shokraneh & Clive E Adams. (2020) Cochrane Schizophrenia Group’s Study-Based Register of Randomized Controlled Trials: Development and Content Analysis. Schizophrenia Bulletin Open 1:1.
Crossref
Jiao Zhai, Shuhong Yi, Yanwei Jia, Pui-In Mak & Rui P. Martins. (2019) Cell-based drug screening on microfluidics. TrAC Trends in Analytical Chemistry 117, pages 231-241.
Crossref
Alessandro Carugo & Giulio F. Draetta. (2019) Academic Discovery of Anticancer Drugs: Historic and Future Perspectives. Annual Review of Cancer Biology 3:1, pages 385-408.
Crossref
Balint Horvath, Nesrine Khazami, Prespa Ymeri & Csaba Fogarassy. (2019) INVESTIGATING THE CURRENT BUSINESS MODEL INNOVATION TRENDS IN THE BIOTECHNOLOGY INDUSTRY. Journal of Business Economics and Management 20:1, pages 63-85.
Crossref
Juliana Santos-Gandelman & Alice Machado-Silva. (2019) Drug development for cryptococcosis treatment: what can patents tell us?. Memórias do Instituto Oswaldo Cruz 114:0.
Crossref
Sandrine Bongiovanni, Robert Purdue, Oleg Kornienko & René Bernard. 2020. Good Research Practice in Non-Clinical Pharmacology and Biomedicine. Good Research Practice in Non-Clinical Pharmacology and Biomedicine 1 17 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.